Stanford professor Russ Altman emphasizes that AI is opening new opportunities to understand how medicines interact with specific proteins, and build more highly customized therapies. He points to DeepMind’s AlphaFold 2 deep learning system as a particularly powerful new tool for re-envisioning how drugs are discovered and designed.
Related
Jessica Jackley,
Kiva
‘What If?’ Changes the World [Entire Talk]
Asking “What if?” can change the whole story.
Jessica Jackley,
Kiva
‘What If?’ Changes the World [Entire Talk]
Asking “What if?” can change the whole story.
Sarah Lamaison,
Dioxycle
Climate Tech Insights [Entire Talk]
Climate tech entrepreneurs are an essential part of reducing and removing carbon emissions.
Sarah Lamaison,
Dioxycle
Climate Tech Insights [Entire Talk]
Climate tech entrepreneurs are an essential part of reducing and removing carbon emissions.
Michelle Lee,
Medra
From Conviction to Company [Entire Talk]
From finding conviction in their ideas to deciding how to grow, detect founders face many decisions.
Michelle Lee,
Medra
From Conviction to Company [Entire Talk]
From finding conviction in their ideas to deciding how to grow, detect founders face many decisions.
